174 related articles for article (PubMed ID: 22290341)
1. Down-regulation of claudin-3 is associated with proliferative potential in early gastric cancers.
Okugawa T; Oshima T; Chen X; Hori K; Tomita T; Fukui H; Watari J; Matsumoto T; Miwa H
Dig Dis Sci; 2012 Jun; 57(6):1562-7. PubMed ID: 22290341
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.
Oshima T; Shan J; Okugawa T; Chen X; Hori K; Tomita T; Fukui H; Watari J; Miwa H
PLoS One; 2013; 8(9):e74757. PubMed ID: 24073219
[TBL] [Abstract][Full Text] [Related]
3. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma.
Satake S; Semba S; Matsuda Y; Usami Y; Chiba H; Sawada N; Kasuga M; Yokozaki H
Pathol Int; 2008 Mar; 58(3):156-63. PubMed ID: 18251778
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.
Montgomery E; Mamelak AJ; Gibson M; Maitra A; Sheikh S; Amr SS; Yang S; Brock M; Forastiere A; Zhang S; Murphy KM; Berg KD
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):24-30. PubMed ID: 16540726
[TBL] [Abstract][Full Text] [Related]
6. Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.
Johnson AH; Frierson HF; Zaika A; Powell SM; Roche J; Crowe S; Moskaluk CA; El-Rifai W
Am J Pathol; 2005 Aug; 167(2):577-84. PubMed ID: 16049341
[TBL] [Abstract][Full Text] [Related]
7. Expression of claudin-2 in the multistage process of gastric carcinogenesis.
Song X; Li X; Tang Y; Chen H; Wong B; Wang J; Chen M
Histol Histopathol; 2008 Jun; 23(6):673-82. PubMed ID: 18366005
[TBL] [Abstract][Full Text] [Related]
8. Differential Notch1 and Notch2 expression and frequent activation of Notch signaling in gastric cancers.
Sun Y; Gao X; Liu J; Kong QY; Wang XW; Chen XY; Wang Q; Cheng YF; Qu XX; Li H
Arch Pathol Lab Med; 2011 Apr; 135(4):451-8. PubMed ID: 21466361
[TBL] [Abstract][Full Text] [Related]
9. Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype.
Soini Y; Tommola S; Helin H; Martikainen P
Virchows Arch; 2006 Jan; 448(1):52-8. PubMed ID: 16220299
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma.
Rohde C; Yamaguchi R; Mukhina S; Sahin U; Itoh K; Türeci Ö
Jpn J Clin Oncol; 2019 Sep; 49(9):870-876. PubMed ID: 31087075
[TBL] [Abstract][Full Text] [Related]
11. Differences in the expression profiles of claudin proteins in human gastric carcinoma compared with non‑neoplastic mucosa.
Yang L; Sun X; Meng X
Mol Med Rep; 2018 Aug; 18(2):1271-1278. PubMed ID: 29901188
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of intestinal claudins in high-risk synchronous and metachronous multiple gastric epithelial neoplasias after initial endoscopic submucosal dissection.
Semba S; Hasuo T; Satake S; Nakayama F; Yokozaki H
Pathol Int; 2008 Jun; 58(6):371-7. PubMed ID: 18477216
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of claudin-2 in normal human tissues and gastrointestinal carcinomas.
Aung PP; Mitani Y; Sanada Y; Nakayama H; Matsusaki K; Yasui W
Virchows Arch; 2006 Apr; 448(4):428-34. PubMed ID: 16328347
[TBL] [Abstract][Full Text] [Related]
14. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
[TBL] [Abstract][Full Text] [Related]
15. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
[TBL] [Abstract][Full Text] [Related]
16. Claudin-6 is down-regulated in gastric cancer and its potential pathway.
Lu YZ; Li Y; Zhang T; Han ST
Cancer Biomark; 2020; 28(3):329-340. PubMed ID: 32390606
[TBL] [Abstract][Full Text] [Related]
17. Gastric pit dysplasia in adjacent gastric mucosa in 414 gastric cancers: prevalence and characteristics.
Shin N; Jo HJ; Kim WK; Park WY; Lee JH; Shin DH; Choi KU; Kim JY; Lee CH; Sol MY; Jeon TY; Kim DW; Huh GY; Kim GH; Lauwers GY; Park DY
Am J Surg Pathol; 2011 Jul; 35(7):1021-9. PubMed ID: 21677540
[TBL] [Abstract][Full Text] [Related]
18. Claudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rate.
Zavala-Zendejas VE; Torres-Martinez AC; Salas-Morales B; Fortoul TI; Montaño LF; Rendon-Huerta EP
Cancer Invest; 2011 Jan; 29(1):1-11. PubMed ID: 20874001
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of claudin-4 in gastric carcinoma.
Zhu JL; Gao P; Wang ZN; Song YX; Li AL; Xu YY; Wang MX; Xu HM
World J Surg Oncol; 2013 Jul; 11():150. PubMed ID: 23822740
[TBL] [Abstract][Full Text] [Related]
20. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue.
Jung H; Jun KH; Jung JH; Chin HM; Park WB
J Surg Res; 2011 May; 167(2):e185-91. PubMed ID: 20462599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
